Systematic review of the development, implementation and availability of smart-phone applications for assessing Type 2 diabetes risk

Diabetic Medicine

Volumn 30, Issue 6, 2013, Pages 758-760

  Gray, L J ^a   Leigh, T ^b   Davies, M J ^b   Patel, N ^a   Stone, M ^a   Bonar, M ^b   Badge, R ^c   Khunti, K ^b  

^a Department of Health Sciences ^*  (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; HEALTH CARE PLANNING; HUMAN; LIFESTYLE MODIFICATION; MOBILE PHONE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TELEMEDICINE; VALIDATION PROCESS;

CELLULAR PHONE; DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HUMANS; INTERNET; LIFE STYLE; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SELF CARE;

EID: 84878053869     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12115     Document Type: Article

References (9)

1. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 2007; 334: 299.
2. Collins GS, Mallett S, Omar O, Yu L. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011; 9: 103.
3. Lindström J, Tuomilehto J. The Diabetes Risk Score. Diabetes Care 2003; 26: 725-731.
4. Gray LJ, Taub N, Khunti K, Gardiner E, Hiles S, Webb DR et al. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multi-ethnic UK setting. Diabet Med 2010; 27: 887-895.
5. Ericsson . Traffic and Market Report, on the Pulse of the Networked Society 2012. Available at http://www.ericsson.com/news/120605_traffic_and_market_report_june_2012_244159019_c Last accessed 04 June 2012.
6. Park PJ, Simmons RK, Prevost AT, Griffin SJ. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. BMC Public Health 2008; 8: 350.
7. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011; 33: 46-62.
8. Fagerlin A, Arbor A, Peters E. Quantitative information. In: Fischhoff B, Brewer NT, Downs JS, eds. Communicating Risks and Benefits. Silver Spring, MD: Food and Drug Administration, 2011.
9. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. Br Med J 2011; 343: d7163.